Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Long-Term Investments: 2009-2024

Historic Long-Term Investments for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.5 billion.

  • UNITED THERAPEUTICS's Long-Term Investments rose 22.50% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 22.50%. This contributed to the annual value of $1.5 billion for FY2024, which is 22.75% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Long-Term Investments of $1.5 billion as of FY2024, which was down 22.75% from $1.9 billion recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Long-Term Investments high stood at $1.9 billion for FY2023, and its period low was $1.1 billion during FY2020.
  • For the 3-year period, UNITED THERAPEUTICS's Long-Term Investments averaged around $1.6 billion, with its median value being $1.5 billion (2024).
  • Per our database at Business Quant, UNITED THERAPEUTICS's Long-Term Investments skyrocketed by 49.79% in 2020 and then fell by 22.75% in 2024.
  • UNITED THERAPEUTICS's Long-Term Investments (Yearly) stood at $1.1 billion in 2020, then surged by 43.52% to $1.6 billion in 2021, then decreased by 20.23% to $1.3 billion in 2022, then skyrocketed by 45.10% to $1.9 billion in 2023, then declined by 22.75% to $1.5 billion in 2024.